| | RA CAPITAL MANAGEMENT, L.P. | IKT | Inhibikase Therapeutics, Inc. | Sell | 18,030,000 | $0.00 | $0.00 |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 27,695 | $0.35 | $9.69K |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 389,216 | $0.35 | $136.23K |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 9,939 | $0.37 | $3.68K |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 139,686 | $0.37 | $51.68K |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 120,216 | $0.39 | $46.88K |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 8,554 | $0.39 | $3.34K |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 11,322 | $0.4 | $4.53K |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 159,119 | $0.4 | $63.65K |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 17,437 | $0.38 | $6.63K |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 245,066 | $0.38 | $93.13K |
| | RA CAPITAL MANAGEMENT, L.P. | JANX | Janux Therapeutics, Inc. | Grant | 5,500 | $0.00 | $0.00 |
| | RA CAPITAL MANAGEMENT, L.P. | PBLS | Parabilis Medicines, Inc. | Conversion | 6,556,740 | $0.00 | $0.00 |
| | RA CAPITAL MANAGEMENT, L.P. | PBLS | Parabilis Medicines, Inc. | Purchase | 19,728,353 | $20 | $394.57M |
| | RA CAPITAL MANAGEMENT, L.P. | PBLS | Parabilis Medicines, Inc. | Purchase | 1,460,397 | $20 | $29.21M |
| | RA CAPITAL MANAGEMENT, L.P. | PBLS | Parabilis Medicines, Inc. | Conversion | 1,187,881 | $0.00 | $0.00 |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 3,051 | $0.37 | $1.13K |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 42,872 | $0.37 | $15.86K |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 345,235 | $0.37 | $127.74K |
| | RA CAPITAL MANAGEMENT, L.P. | HOWL | Werewolf Therapeutics, Inc. | Sale | 24,565 | $0.37 | $9.09K |
| | RA CAPITAL MANAGEMENT, L.P. | ABOS | Acumen Pharmaceuticals, Inc. | Grant | 35,500 | $0.00 | $0.00 |
| | RA CAPITAL MANAGEMENT, L.P. | ACRV | Acrivon Therapeutics, Inc. | Grant | 9,366 | $0.00 | $0.00 |
| | RA CAPITAL MANAGEMENT, L.P. | COAG | Hemab Therapeutics Holdings, Inc. | Purchase | 14,611 | $23.77 | $347.30K |
| | RA CAPITAL MANAGEMENT, L.P. | COAG | Hemab Therapeutics Holdings, Inc. | Purchase | 53,407 | $24.83 | $1.33M |
| | RA CAPITAL MANAGEMENT, L.P. | COAG | Hemab Therapeutics Holdings, Inc. | Purchase | 87,143 | $24.59 | $2.14M |
| | RA CAPITAL MANAGEMENT, L.P. | COAG | Hemab Therapeutics Holdings, Inc. | Purchase | 10,268 | $25 | $256.70K |
| | RA CAPITAL MANAGEMENT, L.P. | COAG | Hemab Therapeutics Holdings, Inc. | Purchase | 2,541,250 | $18 | $45.74M |
| | RA CAPITAL MANAGEMENT, L.P. | COAG | Hemab Therapeutics Holdings, Inc. | Conversion | 1,009,052 | $0.00 | $0.00 |
| | RA CAPITAL MANAGEMENT, L.P. | COAG | Hemab Therapeutics Holdings, Inc. | Conversion | 3,607,846 | $0.00 | $0.00 |
| | RA CAPITAL MANAGEMENT, L.P. | COAG | Hemab Therapeutics Holdings, Inc. | Purchase | 133,750 | $18 | $2.41M |